Birgitta Versluijs

130 Supplemental data TABLE S4. Predictor analyses for IPS. Univariate analyses (N = 15) HR (95% CI) P value Age at HCT 0.9 (0.8-1.0) .12 Sex  Male  Female 1 1.4 (0.8-2.3) .21 HCT indication  Malignancy  Bone marrow failure syndrome  Inborn error of metabolism  Primary immune deficiency 1 0.0 (0-0) 4.8 (1.4-16.5) 2.6 (0.7-10.6) .98 .01 * .17 Conditioning  Chemotherapy-based  TBI-based 1 0.04 (0.0-12.7) .27 Donor  MSD  MUD  uCB 1 1.3 (0.3-6.6) 1.4 (0.4-5.0) .72 .64 HLA matching  MSD 10/10 MUD  9/10 MUD  6/6 uCB  4-5/6 uCB 1 4.3 (0.5-38.5) 1.5 (0.4-6.0) 2.2 (0.6-7.6) .19 .57 .24 CMV serology recipient  Negative  Positive 1 1.2 (0.4-3.7) .75 NPA  RV negative  RV positive 1 2.9 (0.8-10.2) .10 BAL  RV negative  RV positive 1 6.2 (1.7-21.8) .005 * Abbreviations: CMV, Cytomegalovirus; MSD, matched sibling donor; MUD, matched unre- lated donor; TBI, total-body irradiation; uCB, unrelated cord blood. * Statistically significant 7